Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)
India · Delayed Price · Currency is INR 177.50
+5.00 (2.90%)
Oct 1, 2026, 3:12 PM IST
NSE:MADHAVBAUG Revenue
In the fiscal year ending March 31, 2026, Vaidya Sane Ayurved Laboratories had annual revenue of 1.07B INR with 16.58% growth. Vaidya Sane Ayurved Laboratories had revenue of 569.62M in the half year ending March 31, 2026, with 18.10% growth.
Revenue
1.07B
Revenue Growth
+16.58%
P/S Ratio
1.75
Revenue / Employee
2.59M
Employees
413
Market Cap
1.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.07B | 152.02M | 16.58% |
| Mar 31, 2025 | 917.04M | -76.27M | -7.68% |
| Mar 31, 2024 | 993.31M | 1.62M | 0.16% |
| Mar 31, 2023 | 991.69M | 244.58M | 32.74% |
| Mar 31, 2022 | 747.11M | 224.36M | 42.92% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shalby | 11.76B |
| GPT Healthcare | 4.92B |
| Max India | 2.39B |
| Unihealth Hospitals | 1.32B |
| Sangani Hospitals | 1.07B |
| Gaudium IVF and Women Health | 1.06B |
| Gujarat Kidney And Super Speciality | 1.01B |
| Lotus Eye Hospital and Institute | 572.54M |